Statins are competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, a rate-limiting enzyme in cholesterol synthesis. Statins are widely used in the treatment of hypercholesterolemia and to reduce risk of acute cardiovascular and cerebrovascular events. Statins inhibit synthesis of not only cholesterol but also of nonsteroid isoprenoids such as farnesyl-and geranylgeranylpyrophosphate, coenzyme Q (ubiquinone), dolichol, etc., which are involved in multiple cell metabolic and signaling cascades. Adipose tissue may be an important target for statins. Although statins have no effect on body weight and energy balance, they inhibit differentiation of preadipocytes to mature adipocytes and may induce adipocyte apoptosis. Stimulation of lipoprotein lipase in adipose tissue accelerates VLDL metabolism and may contribute to triglyceride-lowering effect of statins. According to some studies, statins reduce insulin sensitivity of adipose tissue and impair glucose metabolism in adipocytes. Statins also inhibit adipose tissue inflammation which plays an important role in obesity-associated pathologies. Finally, statins modulate production of adipokines such as leptin, adiponectin, resistin and visfatin. Currently available data suggest that effects on adipose tissue contribute to both beneficial and adverse consequences of statin therapy. 
Introduction
Stat��s are �ompet�t�ve ������tors of 3��ydroxy�3�met�yl�l�taryl�oe�� zyme A (�M��CoA) red��tase, a rate l�m�t��� e�zyme �� ��olesterol ��osy�t�es�s, ����� �o�verts �M�� CoA to mevalo�ate (F��. 1). C�rre�tly ava�la�le stat��s may �e �lass�fied ��to t�o �ro�ps. �at�ral stat��s ���l�de lovastat��, ����� �s a f���al meta�o� l�te, a�d �ts sy�t�et�� der�vat�ves, prav� astat�� a�d s�mvastat��. Fl�vastat��, atorvastat�� a�d ros�vastat�� are f�lly sy�t�et�� �ompo��ds ��t� �ompletely d�ffere�t ��em��al str��t�re. A�ot�� er sy�t�et�� stat��, �er�vastat��, �as ��t�dra�� from t�e market �� 2001 d�e to ma�y reported �ases of fatal r�a�domyolys�s. A �e� sy�t�et�� sta� t��, p�tavastat��, �as ��trod��ed �� 2003, �o�ever, ��t�l �o� �s ava�la�le o�ly �� Japa� a�d ��d�a.
Stat��s de�rease plasma lo��de�� s�ty l�poprote�� (LDL) ��olesterol �y ��d����� ��tra�ell�lar ��olesterol de� plet�o� a�d �pre��lat��� �epat�� LDL re�eptors. �� add�t�o�, stat��s mod� erately ���rease �DL���olesterol a�d red��e plasma tr��ly�er�des. Ma�y �l����al tr�als �ave demo�strated t�at stat��s effe�t�vely preve�t a��te �ard��
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Statins and adipose tissue 36 REVIEW ovas��lar eve�ts a�d red��e mortal�ty �� pr�mary a�d se�o�dary preve�t�o� of �s��em�� �eart d�sease (1, 2) . ���t�ally ��trod��ed as ��olesterol�lo�er��� dr��s, stat��s posses m�lt�ple ot�er l�p� �d���depe�de�t or "ple�otrop��" at�eroprote�t�ve a�t�v�t�es s��� as �mproveme�t of e�dot�el�al f���t�o�, ������t�o� of ��flamma� tory rea�t�o�, platelet a��re�at�o� a�d t�rom�os�s, a�d amel�o� rat�o� of ox�dat�ve stress. Therefore, �e�efi��al effe�ts of stat��s are o�served �ot o�ly �� pat�e�ts ��t� �yperl�p�dem�a ��t also �� t�ose ��t� �ormal ��olesterol level. �� add�t�o� to �s��em�� �eart d�sease, stat��s may red��e t�e r�sk of �s��em�� stroke, left ve�tr���lar �ypertrop�y, arr�yt�m�as, Alz�e�mer's d�sease, type 2 d�a�etes mell�t�s, slo� t�e pro�ress�o� of ��ro��� �ep�ropa� t��es, r�e�mato�d art�r�t�s a�d m�lt�ple s�leros�s, a�d ���rease �o�e m��eral de�s�ty (3�7). Stat��s ������t t�e rate�l�m�t��� step of t�e mevalo�ate �as� �ade (F��. 1); t�e releva�t prod��ts of ����� �e��� �ot o�ly ��olesterol ��t also ma�y ot�er �ompo��ds referred to as �o�� stero�d �sopre�o�ds. Amo�� t�em, �oe�zyme Q (���q���o�e) �s a� ele�tro� �arr�er �� m�to��o�dr�al resp�ratory ��a�� a�d a� �mporta�t e�do�e�o�s l�p�d�sol��le a�t�ox�da�t prese�t �� plasma mem�ra�es a�d plasma l�poprote��s. Far�esylpyro� p�osp�ate (FPP) a�d �era�yl�era�ylpyrop�osp�ate (��PP) are posttra�slat�o�ally atta��ed to var�o�s small �TP����d��� prote��s s��� as Ras, R�o a�d Ra� ����� re��late �ell �ro�t�, S�mvastat�� a�d lovastat�� are �sed as ��a�t�ve la�to�es ����� are in vivo e�zymat��ally �ydrolyzed to a�t�ve free a��ds (8) . S�mvastat��, lovastat�� a�d atorvastat�� are meta�ol�zed �y �y� to��rome P450 CY3A4 �soform a�d t�e�r meta�ol�sm may �e �mpa�red �y ot�er s��strates or ������tors of t��s e�zyme (9) . Fl�vastat�� �s �ot meta�ol�zed �y CYP3A4 ��t �y CYP2C9. Pravastat�� a�d ros�vastat�� are t�e o�ly stat��s ����� are �� s��sta�t�al amo��ts ex�reted �� �r��e �� t�e ����a��ed form, alt�o��� a�o�t 10% of adm���stered ros�vastat�� �s also meta�� ol�zed �y CYP2C9 (10) . These �ydrop��l�� stat��s are meta�o� l�zed to a m��� lo�er de�ree t�a� ot�er �M��CoA red��tase ������tors a�d t��s are less pro�e to ��tera�t ��t� ot�er CYP s��strates.
Stat��s are ��rre�tly �sed �y 25�30 m�ll�o�s people �orld� ��de, mostly �y t�ose ��t� re�o���zed �ard�ovas��lar d�seases or ��t� ���reased r�sk of t�ese pat�olo��es. �� t�e ot�er �a�d, over�e���t a�d o�es�ty are �mporta�t r�sk fa�tors of �yperl�p�� dem�a, at�eros�leros�s, arter�al �yperte�s�o� a�d �eart fa�l�re. �� add�t�o�, �mpa�red �l��ose tolera��e or type 2 d�a�etes are freq�e�tly o�served �� over�e���t/o�ese s���e�ts a�d are ofte� a��ompa��ed �y dysl�p�dem�a. Th�s, t�e lar�e fra�t�o� of stat��� treated pat�e�ts �ave ex�ess of ad�pose t�ss�e a�d t�erefore, t�e effe�t of stat��s o� t��s t�ss�e �s �l����ally s����fi�a�t. �o�ever, �� �ompar�so� to a �reat �ody of data a�o�t stat��s a���m�lated over t�e last t�o de�ades, relat�vely l�ttle �s k�o�� a�o�t t�e�r ef� fe�ts o� ad�pose t�ss�e. �� t��s art��le � rev�e� t�e ��rre�t k�o�l� ed�e �� t��s field.
Effect of statins on body weight and energy balance
Most st�d�es �ave s�o�� �o effe�t of stat��s adm���stered at p�arma�olo���al doses o� food ��take, e�er�y expe�d�t�re, �ody �e���t a�d ad�pos�ty �� a��mals fed sta�dard d�et (11, 12) . �� add�t�o�, �o �ross effe�t of stat��s o� �ody �e���t or ad�pos� �ty �as o�served �� stat���treated pat�e�ts. Re�e�tly, Arak� et al (13) �ave demo�strated t�at pravastat�� (100 m�/k� for 28 days) de�reased �e���t �a�� a�d v�s�eral fat a���m�lat�o� �� m��e fed ������alor�e d�et. Moreover, pravastat�� ���reased oxy�e� �o�s�mpt�o� a�d red��ed resp�ratory q�ot�e�t. These res�lts s���est t�at stat��s may preve�t t�e developme�t of o�es�ty �y ���reas��� e�er�y expe�d�t�re. �o�ever, t�e dose of pravastat�� �sed �� t��s st�dy �as ����er t�a� �� most exper�me�tal st�d�es. �� add�t�o�, t�ese res�lts �eed to �e �o�firmed for ot�er stat��s a�d ot�er models of o�es�ty.
Effect of statins on adipocyte differentiation and survival
D�ffere�t�at�o� of pread�po�ytes to ad�po�ytes �s esse�t�al for ad�pose t�ss�e �ro�t� a�d also �s a �r���al pro�ess �� t�e de� velopme�t of o�es�ty. W�e� t�e amo��t of tr��ly�er�des a���� m�lated per ea�� ex�st��� ad�po�yte rea��es t�e t�res�old level, �ovel pread�po�ytes are re�r��ted to d�ffere�t�ate ��to mat�re fat �ells a�d a���m�late t�e s�rpl�s of ava�la�le e�er�y. From t��s mome�t, o�es�ty �e�omes "�yperplast��" (more fat �ells) ��stead of �ypertrop��� (more tr��ly�er�des/�ell ��t ����a��ed �ell ��m�er). �yperplast�� o�es�ty �s more res�sta��e to treat� me�t s���e ���rease �� t�e amo��t of ad�po�ytes �s �rrevers��le. Pread�po�yte d�ffere�t�at�o� �s ���t�ated �y t�o tra�s�r�pt�o� fa�tors: perox�some prol�ferator�a�t�vated re�eptor�γ (PPAR�γ) a�d CCAT e��a��er����d��� prote���α (C/�BP�α), ����� re��� late t�e express�o� of ad�po�yte�spe��fi� �e�es s��� as e�zymes ��volved �� tr��ly�er�de stora�e, lept��, ad�po�e�t�� et�. �� t�e ot�er �a�d, pread�po�yte fa�tor�1 (Pref�1) �s a ma�or ������tor of pread�po�yte d�ffere�t�at�o�.
Several st�d�es �ave demo�strated t�at var�o�s stat��s ��� ����t pread�po�yte d�ffere�t�at�o� in vitro. ��s��o et al (14) first demo�strated t�at lovastat�� a�d s�mvastat�� ������ted d�ffere�� t�at�o� of ��lt�red m�r��e 3T3�L1 pread�po�ytes as ev�de��ed �y red��ed ��m�er of l�p�d droplets a�d t�e amo��t of tr��� ly�er�des �� stat���treated �ells. Th�s effe�t �as amel�orated �y mevalo�ate, far�esyl� or �era�yl�era�ylpyrop�osp�ate ��t �ot �y sq�ale�e or ��olesterol. These res�lts ��d��ate t�at t�e effe�t of stat��s �s med�ated �y deplet�o� of �o��stero�d �sopre�o�ds. These o�servat�o�s �ere later �o�firmed �y ot�er a�t�ors (15) a�d also �� ot�er �ell l��es ���l�d��� �o�e marro� stromal �ells (16�18).
Red yeast r��e �as �ee� �sed as a �at�ral food �olora�t a�d preservat�ve, a�d as a trad�t�o�al med����e for �mprov��� food d��est�o� a�d �lood ��r��lat�o� �� or�e�tal �o��tr�es. ��terest� ���ly, red yeast r��e extra�t, ����� �o�ta��s lovastat��, dose�de� pe�de�tly de�reased d�ffere�t�at�o� of 3T3�L1 �ells as ev�de��ed �y red��ed a�t�v�ty of a key e�zyme of tr��ly�er�de sy�t�es�s, �ly�erol 3�p�osp�ate de�ydro�e�ase (�PD�), de�reased tr��� ly�er�de �o�te�t, a�d 30�50% fall �� t�e express�o� of PPAR�γ, C/�BP�α, ad�po�yte fatty a��d����d��� prote���2 (aP2) a�d lep� t�� (19) .
����olso� et al (20) o�served t�at p�tavastat�� red��ed PPAR�γ a�d ���reased Pref�1 express�o� �� 3T3�L1 �ells ���le �av��� �o effe�t o� PPAR�γ D�A����d��� a�t�v�ty. S�rpr�s� ���ly, p�tavastat�� ���reased C/�BP�α express�o�. �o�ever, re� d��t�o� of PPAR�γ a�d st�m�lat�o� of Pref�1 �ere s�ffi��e�t to ������t �ell d�ffere�t�at�o�, as ev�de��ed �y red��ed ��m�er of l�p�d droplets, tr��ly�er�de �o�te�t, fatty a��d ���d��� prote��s (CD36 a�d aP2), sol�te �arr�er 2A4 (SLC2A4)/�l��ose tra�s� porter �LUT4 express�o� a�d ad�ps�� se�ret�o�. ��terest���ly, alt�o��� t�ese effe�ts of p�tavastat�� �ere reprod��ed �y ros�v� astat�� a�d s�mvastat��, t�ey �ere �ot preve�ted �y mevalo�ate or ��olesterol, s���est��� t�at a�t��ad�po�e��� effe�t of stat��s �s ��depe�de�t of t�e ������t�o� of �M��CoA red��tase. �� �mmortal�zed m�r��e ep�dyd�mal pread�po�ytes, atorvastat�� red��ed l�p�d a���m�lat�o�, C/�BP�α express�o� a�d �mpa�red ��s�l���st�m�lated l�po�e�es�s (21) .
�� �o�trast, Fa�as et al (22) �ave s�o�� t�at treatme�t of 3T3� L1 �ells ��t� e�t�er s�mvastat�� or mevastat�� ���reased PPAR�γ express�o�. Th�s effe�t �as med�ated �y stat�����d��ed a�t�va� t�o� of sterol respo�se eleme�t����d��� prote���1 (SR�BP�1) -tra�s�r�pt�o� fa�tor a�t�vated �y ��olesterol deplet�o�. The d�ffere��e �et�ee� res�lts of t��s st�dy a�d st�d�es me�t�o�ed a�ove �s most l�kely asso��ated ��t� ��lt�re �o�d�t�o�s -a�t�ors �sed ��olesterol�free med��m ����� favored stat�����d��ed ��olesterol deplet�o�. �� ��olesterol�replete med�a stat��s are ��l�kely to red��e ��tra�ell�lar ��olesterol s��sta�t�ally ��t re� d��e �o��stero�d �sopre�o�ds. �� add�t�o�, lo�er stat�� �o��e�� trat�o� (0.5 μM vs. 1�10 μM �� ot�er st�d�es) �as �sed (22) .
Re�e�tly, Madse� et al (23) �ave demo�strated t�at l�pop��l�� s�mvastat�� ��d��es apoptos�s of d�ffere�t�at��� 3T3�L1 pread�� po�ytes ��t �ot of d�ffere�t�ated �ells. The effe�t of s�mvastat�� �as preve�ted �y sy�t�et�� l�ver X re�eptor (LXR) a�o��sts, T0901317 a�d �W3965. LXR are l��a�d�a�t�vated tra�s�r�p� t�o� fa�tors ����� �eterod�mer�ze ��t� t�e ret��o�d X re�ep� tor a�d, �po� l��a�d ���d���, re��late t�e express�o� of tar�et �e�es. LXR are a�t�vated �y e�do�e�o�s e�zymat��ally�formed oxy�e�ated ��olesterol der�vat�ves (oxysterols) s��� as 24(S)�, 25� or 27��ydroxy��olesterol as �ell as �y 24(S),25�epoxy��o� lesterol, t�e prod��t of t�e "s���t pat��ay" of t�e mevalo�ate �as�ade (F��. 1). A�t�vated LXR st�m�late t�e express�o� of �e�es ��volved �� reverse ��olesterol tra�sport, �ts �o�vers�o� to ��le a��ds a�d ��l�ary ex�ret�o�. �� add�t�o�, LXR ������t ��test�� �al ��olesterol a�sorpt�o� a�d ��olesterol sy�t�es�s. �� add�t�o�, LXR re��late ot�er pro�esses s��� as �mm���ty, ��flammat�o�, �ervo�s a�d reprod��t�ve system f���t�o�s. Several st�d�es �ave demo�strated t�at stat��s de�rease oxysterol �o��e�trat�o�s; es� pe��ally t�e level of 24(S),25�epoxy��olesterol, a�d de�rease t�e express�o� of LXR tar�et �e�es (24, 25) . Madse� et al. �ave dem� o�strated t�at proapoptot�� effe�t of s�mvastat�� �as �ot asso��� ated ��t� t�e red��t�o� of e�t�er PPAR�γ or SR�BP express�o� or ��t� t�e ������t�o� of ��s�l���l�ke �ro�t� fa�tor�1 (��F�1)���� d��ed a�t�vat�o� of pros�rv�val prote�� k��ase B (PKB)/Akt. �� �o�trast, stat�����d��ed �ell deat� �as a��ravated �y LXRα a�d LXRβ �e�e k�o�ko�ts a�d �as a�ol�s�ed �y for�ed express�o� of �o�st�t�t�vely a�t�ve LXRα (23) . Ma�ser et al (21) �ave dem� o�strated t�at atorvastat�� ��d��es apoptos�s of d�ffere�t�at��� m�r��e ep�dyd�mal pread�po�ytes ��t �ot of mat�re ad�po�ytes. Th�s effe�t res�lted from t�e ������t�o� of PKB/Akt p�osp�or� ylat�o�.
Role of adipose tissue in the effect of statins on plasma lipoproteins
�t �as �ee� re�o���zed for a lo�� t�me t�at plasma ��olesterol �o��e�trat�o� �s proport�o�al to �ody �e���t, ����� s���ests t�e l��k �et�ee� ad�pose t�ss�e a�d ��olesterol meta�ol�sm. ��� deed, ad�pose t�ss�e �o�ta��s more ��olesterol t�a� l�ver, m�s�le or k�d�ey ��e� expressed o� a per m� prote�� �as�s, a�d more t�a� all ot�er or�a�s ��e� expressed o� a per � of t�ss�e �a� s�s. Ad�pose t�ss�e ��olesterol pool �o�st�t�tes a�o�t 25% of t�e ��ole��ody ��olesterol �o�te�t a�d may ���rease �p to 50% �� o�ese s���e�ts. �o�ever, ��olesterol t�r�over �� ad�pose t�ss�e �s relat�vely slo�. The a�t�v�ty of ��olesterol ��osy�t�es�s pat�� �ay �� ad�po�ytes �s lo�er t�a� �� ot�er t�ss�es a�d most of ��olesterol �s prov�ded �y plasma l�poprote��s. Th�s, alt�o��� l�pop��l�� stat��s are expe�ted to a���m�late �� fat �ells �� s��� sta�t�al amo��ts, �t �s ��l�kely t�at ad�pose t�ss�e �o�tr���tes s����fi�a�tly to stat�����d��ed ������t�o� of ��olesterol sy�t�e� s�s (26) . D�e to lo� ��olesterol sy�t�es�s ��t ���� ��olesterol dema�d, espe��ally for a ���ld��p of plasma mem�ra�e �� rap� �dly �ro���� ad�po�yte d�r��� tr��ly�er�de a���m�lat�o�, fat �ells take��p ��olesterol �ot o�ly from LDL ��t also from �DL t�ro��� at least t�o me��a��sms (27) : (i) s�ave��er re�eptor type B1 (SR�B1)�depe�de�t (2/3 of ��olesterol �ptake), a�d (ii) SR�B1 ��depe�de�t, ����� req��res ��olesterol ester tra�s� fer prote�� (C�TP), apol�poprote�� � a�d LDL re�eptor�related prote�� (LRP). Z�ao et al (28) �ave demo�strated t�at �������o� lesterol d�et de�reases SR�B1 express�o� �� ra���t s����ta�eo�s ad�pose t�ss�e, ��ereas atorvastat�� adm���stered at 2.5 m�/k�/ day for 6 �eeks reverses t��s effe�t. �o�ever, t�e �mpl��at�o�s of t��s effe�t of atorvastat�� for ��olesterol �ala��e of ad�po�ytes �s ���lear.
�t �s �ell k�o�� t�at stat��s red��e �ot o�ly plasma ��oles� terol ��t also tr��ly�er�de �o��e�trat�o�. The me��a��sm of t�e latter effe�t ���l�des ������t�o� of �epat�� VLDL format�o� ��t also e��a��eme�t of t�e�r �leara��e. Apart from skeletal m�s� �les, ad�pose t�ss�e �s t�e most �mporta�t s�te of l�poprote�� l�� pase (LPL)�dr�ve� VLDL meta�ol�sm. The effe�t of stat��s o� LPL �� ad�pose t�ss�e �s �o�trovers�al. �� v�tro, pravastat��, s�m� vastat��, atorvastat�� a�d p�tavastat�� ���reased LPL express�o� a�d a�t�v�ty �� 3T3�L1 ad�po�ytes (29, 30) . �� �o�trast, �� v�vo st�d�es are �ot so ��am����o�s. For ��sta��e, atorvastat�� a�d pravastat�� ���reased LPL a�t�v�ty �� pat�e�ts ��t� type 2 d�a�e� tes a�d �yper��olesterolem�a (31, 32) a�d s�mvastat�� (��t �ot atorvastat��) �ad a s�m�lar effe�t �� ��olesterol�fed ra���ts (33) . S�mvastat�� adm���stered at a very ���� dose (120 m�/k�) for 4 days ���reased LPL a�t�v�ty �� ad�pose t�ss�e of �ormal rats. �� add�t�o�, s�mvastat�� red��ed apol�poprote�� C���� (t�e LPL ��� ����tor) level (34) . �� �o�trast, lovastat�� (4 m�/k�/day) ���e�ted s����ta�eo�sly for 13 days �ad �o effe�t o� LPL express�o� �� lept�� re�eptor defi��e�t Z��ker fa/fa rats (35) . S�m�larly, atorv� astat�� ��ve� orally for 2 �eeks at e�t�er 5 or 30 m�/k�/day d�d �ot ��a��e mR�A LPL level �� ad�pose t�ss�e of fr��tose�fed rats, a model of �ypertr��ly�er�dem�a (36) . �t s�o�ld �e �oted t�at stat��s red��ed plasma tr��ly�er�des �� �ot� t�ese st�d�es, ����� ��d��ates t�at st�m�lat�o� of ad�pose t�ss�e LPL �s �ot ��d�spe�� sa�le for tr��ly�er�de�lo�er��� effe�t of t�ese dr��s.
Some st�d�es s���est t�at stat��s m���t affe�t t�e �ala��e �e� t�ee� tr��ly�er�de sy�t�es�s a�d l�polys�s �� ad�pose t�ss�e. For example, atorvastat�� red��ed t�e express�o� of a�ylat�o��st�m� �lat��� prote�� (ASP) a�d e��a��ed t�e express�o� of �ormo�e� se�s�t�ve l�pase (�SL) �� ad�pose t�ss�e of fr��tose�fed rats (36) .
Role of adipose tissue in effect of statins on glucose utilization and insulin sensitivity
The effe�t of stat��s o� �l��ose meta�ol�sm a�d ��s�l�� se�s�� t�v�ty �s �o�trovers�al. �ydrop��l�� pravastat�� �as �ee� demo�� strated to red��e t�e ����de��e of �e��o�set d�a�etes �y 30% (37) . �o�ever, several tr�als �ave demo�strated �orse���� of �l��ose meta�ol�sm �y s�mvastat��, atorvastat�� a�d ros�v� astat�� �� pat�e�ts ��t� pre�ex�st��� d�a�etes (38, 39) , as �ell as ���rease �� t�e rate of o�set of �e� d�a�etes �� �o��d�a�et� �� pat�e�ts treated ��t� t�ese dr��s (40�44). Taka�o et al (45, 46) �ave demo�strated t�at atorvastat��, ��t �ot pravastat�� or p�tavastat��, ���reases plasma �l��ose a�d �ly�ated �emo�lo��� �� A1� �o��e�trat�o�s �� pat�e�ts ��t� type 2 d�a�etes. Atorvas� tat�� �orse�ed �l��ose meta�ol�sm �� rats ��t� streptozoto���� ��d��ed d�a�etes (47) a�d �� o�ese, ��s�l�� res�sta�t a�d moder� ately �yper�ly�em�� �SY m��e (39) .
Ad�pose t�ss�e �s o�e of t�e ma�or s�tes of �l��ose d�sposal a�d a key tar�et for ��s�l��. Th�s, ad�pose t�ss�e may �e t�e ma�� tar�et for ��favora�le effe�t of stat��s o� �l��ose meta�o� l�sm. There are at least t�ree me��a��sms t�ro��� ����� stat��s m���t �mpa�r ��s�l�� se�s�t�v�ty of ad�po�ytes. F�rst, as des�r��ed a�ove, stat��s ������t ad�po�yte d�ffere�t�at�o�. D�ffere�t�ated ad�po�ytes are m��� more ��s�l���se�s�t�ve t�a� �o��mat�re fat �ells. Th�azol�d��ed�o�e der�vat�ves (PPAR�γ a�o��sts), �sed �� t�e treatme�t of type 2 d�a�etes, �mprove ��s�l�� se�s�t�v�ty part�ally �y st�m�lat��� ad�po�yte d�ffere�t�at�o�. �akata et al (39) �ave demo�strated t�at atorvastat�� red��es t�e express�o� of SLC2A4/�LUT4, �l��ose tra�sporter ��volved �� ��s�l��� st�m�lated �l��ose �ptake, �� 3T3�L1 ad�po�ytes, ����� res�lts from �mpa�red �ell d�ffere�t�at�o� as ev�de��ed �y t�e s�m�lta� �eo�s red��t�o� of PPAR�γ a�d C/�BP�α express�o�. S�mvasta� t�� �as 1000 t�mes less pote�t a�d pravastat�� �ad �o effe�t at all. Alt�o��� s�mvastat�� �s l�pop��l��, �t �s �sed as a� ��a�t�ve pro�dr�� (s�mvastat�� la�to�e) ����� m�st �e e�zymat��ally �y� drolyzed to free a��d in vivo; t��s �o�ld expla�� �ts lo� pote��y �� ��lt�red ad�po�ytes. �� add�t�o�, atorvastat�� markedly red��ed t�e express�o� of ��s�l�� re�eptor β�s�����t (�R�β). These effe�ts �ere a��ompa��ed �y red��ed ��s�l�����d��ed PKB/Akt p�os� p�orylat�o� a�d �l��ose �ptake. ��terest���ly, atorvastat�� �ad �o effe�t o� SLC2A4/�LUT4 express�o� �� ��lt�red skeletal my� o�ytes ��d��at��� t�at �ts effe�t �s spe��fi� for ad�po�ytes (39) . �� f�lly d�ffere�t�ated 3T3�L1 ad�po�ytes t�e effe�t of atorvastat�� o� SLC2A4 express�o� a�d ��s�l���st�m�lated �l��ose �ptake �as st�ll o�served ��t �as m��� less pro�o���ed t�a� �� d�f� fere�t�at��� �ells. �o�ever, �� �o�trast to �mmat�re ad�po�ytes, atorvastat�� ���reased t�e express�o� of �R�β a�d ��s�l�� re�ep� tor s��strate�1 (�RS�1) �� f�lly d�ffere�t�ated ad�po�ytes (39) .
Se�o�d, ��s�l�� st�m�lates prote�� far�esyl� a�d �era�yl�era� �yltra�sferases (48, 49) , a�d �sopre�ylated prote��s are ��volved �� some aspe�ts of ��s�l�� s���al���. For example, Ra�4 prote�� �s ��volved �� ��tra�ell�lar ves���lar tra�sport of SLC2A4/�LUT4 from ��a�t�ve ��tra�ell�lar pool to t�e plasma mem�ra�e; t�e key pro�ess �� ��s�l�����d��ed �l��ose �ptake. Taka��r� et al (50) �ave re�e�tly demo�strated t�at atorvastat�� ��t �ot pravasta� t�� de�reases ��s�l�����d��ed 2�deoxy�l��ose �ptake �y mat�re 3T3�L1 ad�po�ytes �y atte��at��� ��s�l�����d��ed tra�slo�a� t�o� of SLC2A4/�LUT4 to t�e plasma mem�ra�e. Atorvastat�� �ad �o effe�t o� ��s�l�����d��ed tyros��e p�osp�orylat�o� of t�e �R�β as �ell as o� a�sol�te level of SLC2A4/�LUT4 mR�A a�d prote��, s���est��� t�at �mpa�red tra�slo�at�o� of �l��ose REVIEW tra�sporter plays a ma�or role �� �mpa�r��� ��s�l�� se�s�t�v�ty. The effe�t of atorvastat�� �as a��ompa��ed �y t�e ���rease �� t�e amo��t of Ra�4 �� t�e �ytosol�� fra�t�o� a�d de�rease �� �ts �o�� te�t �� t�e mem�ra�e fra�t�o�. S���e tra�slo�at�o� of Ra�4 to t�e mem�ra�e fra�t�o� �s depe�de�t o� �ts �sopre�ylat�o�, t�ese data s���est t�at atorvastat�� �mpa�rs SLC2A4/�LUT4 tra�slo� �at�o� se�o�dar�ly to atte��at��� �sopre�ylat�o� of Ra�4.
F��ally, var�o�s stat��s �mpa�red �ly�osylat�o� of ��s�l�� re� �eptor �� 3T3�L1 ad�po�ytes, ����� res�lted �� �mpa�red tra�s� lo�at�o� of t��s re�eptor to t�e plasma mem�ra�e a�d a���m�� lat�o� of ���ly�osylated re�eptors �� e�doplasm�� ret���l�m (51) . Th�s effe�t, as �ell as �mpa�rme�t of ��s�l�����d��ed �l�� �ose �ptake, �as reprod��ed �y sele�t�ve ������tors of prote�� �ly�osylat�o� ��t �ot �y far�esyltra�sferase ������tors. Th�s, stat�����d��ed dol���ol defi��e��y may �mpa�r ��s�l�� s���al��� �y ��terfer��� ��t� ��s�l�� re�eptor �ly�osylat�o�.
Statins and adipose tissue inflammation
Re�e�t st�d�es ��d��ate t�at o�es�ty a�d t�e meta�ol�� sy�� drome are asso��ated ��t� ��ro��� lo���rade ��flammat�o� of t�e ad�pose t�ss�e a��ompa��ed �y a���m�lat�o� of ma�� rop�a�es a�d mast �ells ����� express pro��flammatory �y� tok��es s��� as t�mor �e�ros�s fa�tor�α (T�F�α), mo�o�yte ��emoattra�ta�t prote���1 (MCP�1) or ��terle�k���6 (�L�6); some of t�em �e��� sy�t�es�zed also �y ad�po�ytes t�emselves. Ad�pose t�ss�e ��flammat�o� �o�tr���tes to ��s�l�� res�sta��e a�d a��ormal�t�es of �l��ose meta�ol�sm asso��ated ��t� o�es� �ty. Ad�pose t�ss�e ��flammat�o� �s dr�ve�, at least �� part, �y a�t�vat�o� of l�popolysa���ar�de (LPS) re�eptor, Toll�l�ke re� �eptor�4 (TLR�4), �y sat�rated fatty a��ds, a�d �y �ypox�a (see Tray��r� et al �� t��s vol�me of Adipobiology). A�e et al (52) �ave demo�strated t�at pravastat�� or p�tavastat�� adm���s� tered to lept���defi��e�t ob/ob m��e red��ed t�e express�o� of MCP�1, T�F�α a�d �L�6 �e�es �� ep�dyd�mal a�d s����ta�e� o�s ad�pose t�ss�e. Stat��s �ad �o effe�t o� �ody �e���t as �ell as o� t�e amo��t of ma�rop�a�es �� ad�pose t�ss�e. In vitro st�d�es revealed t�at �o�d�t�o�ed med��m of ��lt�red LPS� treated ma�rop�a�es st�m�lated ��flammatory respo�se of ad�po�ytes ��t t��s effe�t �as s�ppressed �f ma�rop�a�es (��t �ot ad�po�ytes) �ee pretreated ��t� stat��s. ��deed, pravasta� t�� a�d p�tavastat�� red��ed t�e express�o� of MCP�1, T�F�α, �L�6 a�d ��d����le ��tr�� ox�de sy�t�ase (���S) �� LPS�treated ma�rop�a�es. The TLR�4 re�eptor tr���ers t�o s���al��� pat�� �ays: (i) re�r��tme�t of Toll/�L�1 re�eptor (T�R)�doma����o�� ta����� adaptor prote�� MyD88, ����� t�e� a�t�vates ���lear fa�tor�κB (�F�κB) a�d ��J�� ��term��al k��ase (J�K), a�d (ii) re�r��tme�t of T�R doma����o�ta����� adaptor ��d����� �F��γ (TR�F), lead��� to t�e a�t�vat�o� of tra�s�r�pt�o� fa�tor �RF3 ����� t�e� a�t�vates �F��γ promoter a�d st�m�lates �ts sy�t�es�s. Stat��s ������ted p�osp�orylat�o� of �RF3, sy�t�es�s of �F��γ, a�d p�osp�orylat�o� of �ts s���al��� tar�et, STAT1 prote��. �� �o�trast, pravastat�� or p�tavastat�� �ad �o effe�t o� MyD88�depe�de�t s���al���. Colle�t�vely, t�ese data ��d�� �ate t�at stat��s ������t MyD88���depe�de�t TLR�4 s���al��� �� ad�pose t�ss�e ma�rop�a�es lead��� to t�e atte��at�o� of �F��γ format�o� a�d red��t�o� of pro��flammatory respo�se of ad�po�ytes as �ell as ma�rop�a�es t�emselves (52) . Treat� me�t ��t� atorvastat�� red��ed prod��t�o� of C�rea�t�ve pro� te�� (CRP) (53), �L�6 (54), a�d T�F�α (55) �y ad�po�ytes of ��olesterol�fed ra���ts. In vitro, atorvastat�� (54) a�d �er�vas� tat�� (56) de�reased �L�6 express�o� �y ��lt�red ra���t a�d ��� ma� ad�po�ytes. F��ally, s�mvastat�� a�d pravastat�� de�reased �ytok��e�st�m�lated express�o� of ���S �� 3T3�L1 ad�po�ytes (57) . Red��t�o� of ad�pose t�ss�e ��flammat�o� may �o�tr���te to �e�efi��al effe�ts of stat��s o� ��s�l�� se�s�t�v�ty a�d also to t�e ������t�o� of at�ero�e�es�s.
Statins and adipokines
Ad�pok��es play a� �mporta�t role �� ad�pose t�ss�e p�ys�olo�y a�d �� o�es�ty�asso��ated �ompl��at�o�s (58) . �ere��, � fo��s o� effe�t of stat��s o� most exte�s�vely st�d�ed ad�pok��es: lept��, ad�po�e�t��, res�st�� a�d v�sfat��.
Leptin
Z�ao et al (59) �ave demo�strated t�at �������olesterol d�et ���reases plasma lept�� �o��e�trat�o� �� t�e ra���t more t�a� 2�fold ��t�o�t ��a����� �ody �e���t or ad�pos�ty. Co��om�� ta�t treatme�t ��t� atorvastat�� red��ed ser�m lept�� a�d lep� t�� mR�A �� s����ta�eo�s ad�pose t�ss�e s�m�lta�eo�sly ��t� de�reas��� LDL���olesterol ��t �ad �o effe�t o� �ody �e���t. These data s���est t�at stat��s may de�rease lept�� level. The me��a��sm of t��s effe�t �s ���lear ��t may ���l�de red��t�o� of e�t�er ad�pose t�ss�e ��flammat�o� or ox�dat�ve stress �e�a�se �ot� t�ese �o�d�t�o�s st�m�late lept�� prod��t�o�.
�ffe�t of stat��s o� plasma lept�� �o��e�trat�o� �� ��ma�s �as addressed �� 9 �l����al st�d�es (Ta�le 1). �� most of t�em, stat��s d�d �ot ��a��e lept�� level s����fi�a�tly. ��e st�dy dem� o�strated de�rease a�d o�e ���rease �� lept��. Ko� et al (63) �ompared t�e effe�t of s�mvastat�� a�d pravastat�� �� a �ross� over st�dy �� t�e same �ro�p of �yper��olesterolem�� pat�e�ts. They o�served t�at l�pop��l�� s�mvastat�� ��t �ot �ydrop��l�� pravastat�� ���reased ser�m lept�� �o��e�trat�o�. Alt�o��� t�ese data s���est t�at var�o�s stat��s may �ave d�ver�e�t effe�ts o� lept�� level, t�e overall a�alys�s of data prese�ted �� Ta�le 1 ��d��ates t�at mod�lat�o� of lept�� plays o�ly a m��or role �� t�e effe�t of stat��s.
Adiponectin
Ma�ser et al (21) �ave demo�strated t�at atorvastat�� red��ed ad�po�e�t�� express�o� �� d�ffere�t�ated 3T3�L1 ad�po�ytes. �� �o�trast, pravastat�� ���reased ad�po�e�t�� se�ret�o� �� t�e same �ell ��lt�re, a�d �pre��lated ad�po�e�t�� �e�e express�o� a�d elevated �ts plasma level �� lept�� re�eptor defi��e�t db/db m��e as �ell as �� �����fat a�d �����s��rose fed C57BL/6J m��e (69) . Th�s effe�t of pravastat�� �orrelated ��t� t�e �mproveme�t of ��s�l�� se�s�t�v�ty a�d �as �ot a��ompa��ed �y a�y ��a��es �� �ody �e���t. S�mvastat�� d�d �ot ��a��e e�t�er ad�po�e�t�� level or ��s�l�� se�s�t�v�ty. A�t�ors s���est t�at effe�t o� ad�� po�e�t�� may expla�� d�ffere�t�al ��fl�e��e of �ydrop��l�� a�d l�pop��l�� stat��s o� �l��ose meta�ol�sm (69) .
Alt�o��� lept�� �s t�e �est ��ara�ter�zed ad�pok��e, m��� more st�d�es addressed t�e effe�t of stat��s o� ad�po�e�t�� �� var�o�s pat�e�t �ro�ps. Amo�� t�em, ���rease, de�rease or �o ��a��e �� ad�po�e�t�� follo���� stat�� treatme�t �as �oted �� 20, 4 a�d 20 st�d�es, respe�t�vely (Ta�le 2). �f ��a��es �� ad�� po�e�t�� �ere o�served, t�ey �ere relat�vely small, rarely ex� �eed��� 20�30%. The lar�est effe�t �as o�served for ros�vastat�� (73) . A�t�ors ��o o�served ���rease �� ad�po�e�t�� �s�ally s��� �est t�at �t m���t �o�tr���te to a�t�at�ero�e��� a�d a�t�d�a�et�� 
Resistin
S�mvastat�� ������ted C�rea�t�ve prote�����d��ed �pre��lat�o� of res�st�� �e�e express�o� �� ��ma� per�p�eral �lood mo�o� �ytes (102) . The effe�t of s�mvastat�� �as reversed �y mevalo�ate a�d �era�yl�era�ylpyrop�osp�ate ��t �ot �y far�esylpyrop�os� p�ate. S�m�larly, atorvastat�� red��ed res�st�� �e�e express�o� �� m�r��e 3T3�L1 ad�po�ytes, ��lt�red ��ma� pread�po�ytes a�d mo�o�yte�ma�rop�a�es (103, 104) . �� most �l����al st�d�es, �o effe�t of stat��s o� plasma res�st�� level �as reported (Ta�le 3). Th�s, �t seems ��l�kely t�at red��� t�o� of res�st�� �s ��volved �� �e�efi��al effe�ts of stat��s. 
Conclusions
Stat��s �ave m�lt�ple effe�ts �� v�rt�ally all t�ss�es a�d ad�� pose t�ss�e �s �ot a� ex�ept�o�. Most of ��rre�tly �sed stat��s are l�pop��l�� a�d t��s expe�ted to a���m�late �� s��sta�t�al amo��ts �� ad�pose t�ss�e. C�rre�tly ava�la�le data ��d��ate t�at alt�o��� stat��s �ave �o �ross effe�t o� �ody ad�pos�ty, ad�pose t�ss�e may �e t�e tar�et for �ot� �e�efi��al a�d adverse effe�ts of t�ese dr��s. Stat��s ������t ad�po�yte d�ffere�t�at�o�, �mpa�r ��s�l�� s���al��� �� fat �ells, ������t ad�pose t�ss�e ��flamma� t�o�, a�d mod�late ad�pok��e sy�t�es�s a�d se�ret�o�. �o�ever, ma�y effe�ts of stat��s o� ad�pose t�ss�e are �o�trovers�al, es� pe��ally t�e�r ��fl�e��e o� VLDL �leara��e a�d ad�pok��e pro� d��t�o�. Ma�y res�lts �ere o�ta��ed �� ��lt�red ad�po�yte �ell l��es a�d t��s do �ot �e�essar�ly refle�t �� v�vo s�t�at�o�. More exper�me�tal st�d�es are �eeded to el���date �� more deta�l ef� fe�t of stat��s o� ad�pok��es prod��t�o� a�d t�e me��a��sm of t�ese effe�t, s���e t�e res�lts of �l����al st�d�es are ����ly �o�tro� vers�al. D�e to ���reas��� �sa�e of stat��s �orld��de, el���dat��� t�e�r effe�ts o� ad�pose t�ss�e �s �mporta�t to �mprove t�e res�lts of treatme�t ��t� t�ese dr��s.
